Agonistas de los receptores adrenérgicos β₂ de acción prolongada (LABA)

Los agonistas de los receptores β₂ adrenérgicos de acción prolongada (LABA) son compuestos que estimulan selectivamente los receptores β₂ adrenérgicos en los pulmones, provocando broncodilatación y ayudando a relajar el músculo liso de las vías respiratorias. Los LABA se utilizan comúnmente en el tratamiento de afecciones respiratorias como el asma y la enfermedad pulmonar obstructiva crónica (EPOC) debido a su acción prolongada. En CymitQuimica, ofrecemos una amplia selección de compuestos LABA para la investigación en farmacología respiratoria y aplicaciones terapéuticas.

20
- 50
- 100
- 200

productos por página. Hay 329 productos en esta categoría.

Datos del producto	Pureza	Rango de precios	Entrega estimada
Phenylpropoxy Salmeterol (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) REF: 45-1A04700CAS: 94749-11-8	- - -	2.406,00 €	Vie 03 Ene 25
Salmeterol Xinafoate REF: 45-1609603CAS: 94749-08-3	- - -	1.210,00 €	Vie 03 Ene 25
Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol) REF: 45-1609614CAS: 1798014-51-3	- - -	1.699,00 €	Vie 03 Ene 25
Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- REF: 45-1609625CAS: 108928-81-0	- - -	1.477,00 €	Vie 03 Ene 25
Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) REF: 45-1609680CAS: 1330076-52-2	- - -	1.627,00 €	Vie 03 Ene 25
Phenylethoxy Salmeterol (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol) REF: 45-1A04690CAS: 94749-02-7	- - -	1.227,00 €	Vie 03 Ene 25
Fluticasone Propionate REF: 45-1285873CAS: 80474-14-2	- - -	2.063,00 €	Vie 03 Ene 25
Salmeterol Resolution Check REF: 45-1609589	- - -	1.475,00 €	Vie 03 Ene 25
Deoxy Salmeterol (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol) REF: 45-1A04710CAS: 1391054-40-2	- - -	1.554,00 €	Vie 03 Ene 25
Fluticasone Propionate Related Compound J (6α, 9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic acid) REF: 45-1285818CAS: 28416-82-2	- - -	1.477,00 €	Vie 03 Ene 25
Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H) REF: 45-1609590	- - -	1.555,00 €	Vie 03 Ene 25
4-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride) REF: 45-1A04820CAS: 144391-74-2	- - -	1.227,00 €	Vie 03 Ene 25
Indacaterol maleate REF: TM-T1239CAS: 753498-25-8	99.03% - 99.67%	36,00 €~149,00 €	Mar 07 Ene 25
Salmeterol REF: TM-T12829CAS: 89365-50-4	99.87% - 99.9%	54,00 €~458,00 €	Mar 07 Ene 25
Olodaterol REF: TM-T3457CAS: 868049-49-4	98.9%	50,00 €~579,00 €	Mar 07 Ene 25
Formoterol Impurity 44 REF: 4Z-F-1171	- - -	A consultar	Mar 07 Ene 25
Vilanterol Impurity 11 L-Tartrate REF: 4Z-V-058064CAS: 2762285-55-0	- - -	A consultar	Mar 07 Ene 25
Formoterol EP Impurity D (Mixture of Diastereomers) REF: 4Z-F-1156CAS: 1795133-96-8	- - -	A consultar	Mar 07 Ene 25
Salmeterol Impurity 15 REF: 4Z-S-1625CAS: 65843-60-9	- - -	A consultar	Mar 07 Ene 25
Formoterol EP Impurity F (Mixture of Diastereomers) REF: 4Z-F-1114CAS: 1795129-59-7	- - -	A consultar	Mar 07 Ene 25

10mg		36,00 €
25mg		57,00 €
50mg		74,00 €
100mg		100,00 €
200mg		149,00 €
1mL*10mM (DMSO)		55,00 €

5mg		54,00 €
10mg		86,00 €
25mg		151,00 €
50mg		270,00 €
1mL*10mM (DMSO)		77,00 €

Agonistas de los receptores adrenérgicos β₂ de acción prolongada (LABA)

Phenylpropoxy Salmeterol (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)

Ref: 45-1A04700

Salmeterol Xinafoate

Ref: 45-1609603

Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol)

Ref: 45-1609614

Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-

Ref: 45-1609625

Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)

Ref: 45-1609680

Phenylethoxy Salmeterol (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol)

Ref: 45-1A04690

Fluticasone Propionate

Ref: 45-1285873

Salmeterol Resolution Check

Ref: 45-1609589

Deoxy Salmeterol (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol)

Ref: 45-1A04710

Fluticasone Propionate Related Compound J (6α, 9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic acid)

Ref: 45-1285818

Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)

Ref: 45-1609590

4-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)

Ref: 45-1A04820

Indacaterol maleate

Ref: TM-T1239

Salmeterol

Ref: TM-T12829

Olodaterol

Ref: TM-T3457

Formoterol Impurity 44

Ref: 4Z-F-1171

Vilanterol Impurity 11 L-Tartrate

Ref: 4Z-V-058064

Formoterol EP Impurity D (Mixture of Diastereomers)

Ref: 4Z-F-1156

Salmeterol Impurity 15

Ref: 4Z-S-1625

Formoterol EP Impurity F (Mixture of Diastereomers)

Ref: 4Z-F-1114